Table of Contents
The Pistoia Alliance, a non-profit advocating for increased collaboration in life sciences R&D, has announced a call to action focused on addressing artificial intelligence (AI) regulation and adoption challenges. A survey conducted at the conference revealed that 70% of life sciences experts acknowledge AI's potential, but many are still determining how to properly implement it. The alliance also revealed new projects aimed at supporting clinical trials and AI integration. The United States and the European Union both employ a risk-based approach to AI in the life sciences industry, agreeing on ethics such as accuracy, robustness, data privacy, accountability, transparency, safety, and security. Regulatory requirements for the use of AI and machine learning are evolving, with guiding principles from regulatory agencies in the US, Canada, and the UK.
